We are doing this study because we want to find out if this approach is better or worse than the usual approach for multiple myeloma. The usual approach is defined as care most people get for multiple myeloma.
S1803, Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (DRAMMATIC)
Moorland Reserve Health Center
OPEN TO ACCRUAL